CXSL2101400 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-11-01 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
CXSL2200069 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2022-02-07 | | SinoCelltech Ltd | | | view |
CXSL2101076 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-05-14 | | Taizhou Hanzhong Biomedical Co Ltd | | | view |
CXSL2101434 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-11-22 | | SinoCelltech Ltd | | | view |
CXSL2101051 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-04-30 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
CXSL2101342 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-09-26 | | Taizhou Hanzhong Biomedical Co Ltd | | | view |
CXSL2101395 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-11-01 | | Taizhou Hanzhong Biomedical Co Ltd | | | view |
CXSL1800032 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-04-11 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | Certificate Issued | 2018-07-24 | view |
CXSL2000144 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-07-04 | 山西威奇达光明制药有限公司 | Shanxi Weiqidaguangming Pharmaceutical Co Ltd | In Review | 2020-07-03 | view |
CXSL1400138 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2015-01-21 | 泰州君实生物医药科技有限公司 | Taizhou Junshi Biomedical Technology Co Ltd | Certificate Issued | 2016-01-14 | view |
CXSL2000011 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-01-18 | 泰州翰中生物医药有限公司 | Taizhou Hanzhong Biomedical Co Ltd | In Review | 2020-01-17 | view |
CXSL1600107 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2017-02-22 | 泰州翰中生物医药有限公司 | Taizhou Hanzhong Biomedical Co Ltd | Certificate Issued | 2017-09-14 | view |
CXSL2000022 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-02-14 | 泰州翰中生物医药有限公司 | Taizhou Hanzhong Biomedical Co Ltd | In Review | 2020-02-13 | view |
CXSL1800130 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-01-07 | 百奥泰生物科技(广州)有限公司 | Bio-Thera Solutions Ltd | In Review | 2019-01-04 | view |
CXSL1800123 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-12-25 | 百奥泰生物科技(广州)有限公司 | Bio-Thera Solutions Ltd | In Review | 2018-12-24 | view |
CXSL1800122 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-12-25 | 百奥泰生物科技(广州)有限公司 | Bio-Thera Solutions Ltd | In Review | 2018-12-24 | view |
CXSL1600102 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2017-01-12 | 百奥泰生物科技(广州)有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2017-09-14 | view |
CXSL1800025 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-06 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2018-07-06 | view |
CXSL2000118 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-05-29 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2020-05-28 | view |